Aarti Pharmalabs Board Approves Stock Options Grant for Employees
Aarti Pharmalabs Limited has announced the grant of 57,600 stock options to eligible employees under its APL Performance Stock Option Plan…
Aarti Pharmalabs Financial Results for FY 2025-26 and Dividend Announcement
Aarti Pharmalabs Limited has announced its audited financial results for the quarter and financial year ended March 31, 2026. The Board of…
Orchid Pharma Strong Financial Growth and Strategic Acquisitions Highlight Fiscal Year 2026
Orchid Pharma has reported its audited financial results for the quarter and year ended March 31, 2026. The company achieved standalone annual…
Entero Healthcare Solutions Q4 FY26 Financial Results and Strategic Expansion
Entero Healthcare Solutions has reported its audited financial results for the quarter and financial year ended March 31, 2026. The company…
H.G. Infra Engineering Limited Q4 & FY26 Earnings Conference Call Scheduled
H.G. Infra Engineering Limited has announced its upcoming earnings conference call to discuss the financial results for the quarter and…
Aarti Pharmalabs Announces Q4 and Annual Financial Results, Declares Dividend
Aarti Pharmalabs has announced its audited financial results for the quarter and financial year ended March 31, 2026. The company reported a…
Aarti Pharmalabs Full Year Financial Results and Strategic Leadership Updates
Aarti Pharmalabs reported its financial performance for the year ended March 31, 2026, announcing a final dividend of Rs. 2 per equity share…
Entero Healthcare Solutions Limited Q4 Financial Results and Expansion Initiatives
Entero Healthcare Solutions Limited announced its audited financial results for the quarter and year ended March 31, 2026, reporting a robust…
Sudarshan Chemical Industries Q4 FY26 Performance Highlights and Integration Progress
Sudarshan Chemical Industries has announced its financial results for the quarter and year ended March 31, 2026. The company reports strong…
Entero Healthcare Solutions Limited Q4 Financial Results and Expansion Update
Entero Healthcare Solutions Limited reported a strong Q4 fiscal year 2026, with consolidated revenue reaching ₹19,099.27 million. The company…